Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis

Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment Lewy Body Dementias Prodromal Working Group.

Alzheimers Dement. 2023 Jul;19(7):3186-3202. doi: 10.1002/alz.13105. Epub 2023 Apr 24.

Young Onset Alzheimer's Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association

Vinceti G, Gallingani C, Zucchi E, Martinelli I, Gianferrari G, Simonini C, Bedin R, Chiari A, Zamboni G, Mandrioli J.

Genes (Basel). 2023 Apr 17;14(4):930. doi: 10.3390/genes14040930.

Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays

Hsiao WW, Angela S, Le TN, Ku CC, Hu PS, Chiang WH.

J Alzheimers Dis. 2023;93(3):821-845. doi: 10.3233/JAD-221202.

Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease

Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C.

Mol Psychiatry. 2023 Jul;28(7):2716-2727. doi: 10.1038/s41380-023-02076-1. Epub 2023 May 2.

Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease

Xu Y, Jiang H, Zhu B, Cao M, Feng T, Sun Z, Du G, Zhao Z.

CNS Neurosci Ther. 2023 Aug;29(8):2060-2073. doi: 10.1111/cns.14238. Epub 2023 May 5.

Amyloid PET: A Potential Biomarker for Individuals with Mild Traumatic Brain Injury

Haller S.

Radiology. 2023 Jun;307(5):e230671. doi: 10.1148/radiol.230671. Epub 2023 May 9.

Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta-analysis

García-García I, Fernández-Andújar M, Narváez M, García-Casares N.

Obes Rev. 2023 Aug;24(8):e13573. doi: 10.1111/obr.13573. Epub 2023 May 10.

GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Cells. 2023 May 4;12(9):1309. doi: 10.3390/cells12091309.

Revolutionizing the Early Detection of Alzheimer's Disease through Non-Invasive Biomarkers: The Role of Artificial Intelligence and Deep Learning

Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K, Exarchos TP, Vlamos P.

Sensors (Basel). 2023 Apr 22;23(9):4184. doi: 10.3390/s23094184.

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis

Zabala-Findlay A, Penny LK, Lofthouse RA, Porter AJ, Palliyil S, Harrington CR, Wischik CM, Arastoo M.

Cells. 2023 Apr 18;12(8):1184. doi: 10.3390/cells12081184.

Blood biomarkers for Alzheimer's disease in clinical practice and trials

Hansson O, Blennow K, Zetterberg H, Dage J.

Nat Aging. 2023 May;3(5):506-519. doi: 10.1038/s43587-023-00403-3. Epub 2023 May 18.

Detection and treatment of Alzheimer's disease in its preclinical stage

Rafii MS, Aisen PS.

Nat Aging. 2023 May;3(5):520-531. doi: 10.1038/s43587-023-00410-4. Epub 2023 May 18.

Co-twin design in brain imaging-review on biomarkers of Alzheimer's disease

Varjonen A, Schwarz C, Vuoksimaa E.

Cereb Cortex. 2023 Jul 5;33(14):9054-9066. doi: 10.1093/cercor/bhad181.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias